ArticleFrontiers in genetics2026
Benchmarking major somatic structural variant callers on the HG008 genome.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Somatic structural variants (SVs) are the predominant source of cancer driver mutations and play a critical role in oncogenesis. Comprehensive characterization of somatic SVs is critical for elucidating the mechanisms underlying tumorigenesis and for identifying biomarkers with diagnostic and therapeutic potential. However, their accurate detection remains challenging, primarily because most existing SV detection algorithms were originally developed for germline variants and are not well-suited to addressing the high heterogeneity of somatic mutations. In recent years, although several tools specifically designed for somatic SVs have emerged, their detection performance has not yet been rigorously validated. To bridge this gap, we conducted a comprehensive benchmarking of four leading somatic SV detection tools, namely, Sniffles2, Nanomonsv, Savana, and Severus, on the HG008 genome from Genome in a Bottle Consortium (GIAB). Their outputs were evaluated against the HG008 clonal somatic SV draft benchmark to assess overall performance. We further integrated the somatic SV callsets from multiple tools and compared them with the benchmark set, thereby establishing a multi-tool ensemble strategy for SV detection to achieve more accurate and comprehensive identification of somatic SVs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.